Propel Bio Management »

Kempharm shares owned by Propel Bio Management

Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Kempharm

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.0011.248324M1.2483245M1.248325M1.2483255M1.248326M179.873k179.8735k179.874k179.8745k179.875k
Value ($)Share countHistorical ZVRA position of Propel Bio Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 180k 6.94

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Phathom Pharmaceuticals I Comm (PHAT)
Achieve Life Sciences Comm (ACHV)
Tscan Therapeutics Comm (TCRX)
Akero Therapeutics Comm (AKRO)
Madrigal Pharmaceuticals Comm (MDGL)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Telesat Corp Comm (TSAT)
Abeona Therapeutics Comm (ABEO)
Kymera Therapeutics Comm (KYMR)
Syndax Pharmaceuticals In Comm (SNDX)
Kura Oncology Comm (KURA)
Zevra Therapeutics Comm (ZVRA)

View all positions for Propel Bio Management

Top funds holding Kempharm

Woodline Partners
BlackRock
Adage Capital Partners GP
Vanguard Group
Nantahala Capital Management
FMR
Altium Capital Management
683 Capital Management
Geode Capital Management
State Street Corporation
J. Goldman & Co
Rubric Capital Management
Stonepine Capital Management
Vestal Point Capital
Retirement Planning Co of New England

View all funds holding Kempharm